(2R)-Methyl 2-acetamido-3-chloro-3-hydroxypropanoate

We are (2R)-Methyl 2-acetamido-3-chloro-3-hydroxypropanoate CAS:87333-22-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2R)-Methyl 2-acetamido-3-chloro-3-hydroxypropanoate
CAS.NO:87333-22-0
Synonyms:(2R)-Methyl 2-acetamido-3-chloro-3-hydroxypropanoate
N-acetyl-3-chloro-alanine methyl ester
N-Acetyl-3-chloro-L-serine methyl ester
methyl 3-chloro-2-acetylaminopropionate
DL-3-Chlor-2-acetamino-propionsaeure-methylester
METHYL-2-ACETAMIDO-3-CHLOROPROPIONATE
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 385.6±42.0 °C at 760 mmHg
Melting Point 74-76ºC
Molecular Formula C6H10ClNO4
Molecular Weight 195.601
Flash Point 187.0±27.9 °C
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ramipril(CAS:87333-19-5).

(2R)-Methyl 2-acetamido-3-chloro-3-hydroxypropanoate


Related News: Huahai started with the development of characteristic APIs and pharmaceutical intermediates. At the same time, using the international cooperation platform and the opportunity of the expiry of patent protection of major international original research drugs, Huahai has extended the industrial chain to downstream high value-added preparations, and formed intermediates and materials The complete industrial chain of medicine and preparation integration.2-Hydroxy-6-methylpyridine CAS:3279-76-3 The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.3-Methacryloxypropylmethyldimethoxysilane There is fierce competition for bulk APIs and overcapacity. However, some high-profit, small-scale drugs still have a good market space.2-Bromobenzaldehyde In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.

Related Products
Product Name
(2S)-2-[[(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]amino]propanoic acid View Details
-Butylbenzofuran View Details
1-METHYL-4-(PIPERIDIN-4-YL)-PIPERAZINE View Details
N-Acetylmorpholine manufacturer Hexyl chlorocarbonate manufacturer tetrabutylammonium bromide manufacturer (3R,4S,5R,6R)-2-(dichloromethyl)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol manufacturer 2-Methoxy-5-(trifluoromethyl)benzonitrile manufacturer